Holmberg, T. http://orcid.org/0000-0002-4671-3810
Möller, S.
Rothmann, M.J.
Gram, J.
Herman, A.P.
Brixen, K.
Tolstrup, J.S.
Høiberg, M.
Bech, M.
Rubin, K.H.
Funding for this research was provided by:
INTERREG (4A JNR 08/4177)
Region of Sothern Denmark (JNR 08/8133)
Odense Universitetshospital (JNR 11/5761)
Gigtforeningen
Article History
Received: 29 May 2018
Accepted: 7 November 2018
First Online: 21 November 2018
Compliance with ethical standards
:
: S Möller, T Holmberg M Bech, J Gram, JS Tolstrup, KH Rubin have no conflicts of interest. MJ Rothmann has received a speaking fee from Eli Lilly. M Hoiberg is a full-time employee of Boehringer-Ingelheim Norway KS (currently). AP Hermann serves on advisory Boards for Eli Lilly, Amgen, and she has received research funding from Eli Lilly, a speaking fee from Eli Lilly, GSK, Genzyme, Amgen; K Brixen reports other from Merck, Sharpe, Dohme, other from Amgen, other from Novartis, other from NPS, all outside the submitted work.